BSE filing, NSE: CHOKSILA. Summary written from the filing by ALFA Finder's alert engine.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹213.95
- Market cap
- ₹149.0 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 68.9×Sector 52.0×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Convertible Warrants
Choksi Laboratories' proposed convertible warrants issue was rejected at its EGM on October 17, 2026. The company requests BSE to close the in-principle approval application.
Choksi Laboratories Convertible Warrants
Choksi Laboratories' EGM on 17 Oct 2026 rejected the special resolution to allot convertible warrants to promoters. 99.46% of votes polled were against, blocking the capital raise.
Choksi Laboratories Convertible Warrants
Choksi Laboratories held an EGM regarding the issuance of convertible warrants on a preferential basis. The promoters and proposed allottees abstained from voting on the resolution.
Choksi Laboratories Other Announcement
Choksi Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Choksi Laboratories Capital Structure Change
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
- Value
- ₹6.20 Cr
Other other announcement announcements
All →Refractory Shapes Other Announcement
Refractory Shapes Ltd filed its Integrated Governance filing for the quarter and half year ended 30 Sep 2026. It claims exemption from the Corporate Governance Report and reported zero investor grievances.
Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.